Analysis of occludin trafficking, demonstrating continuous endocytosis, degradation, recycling and biosynthetic secretory trafficking by Fletcher, Sarah J. et al.
 
 
Analysis of occludin trafficking, demonstrating
continuous endocytosis, degradation, recycling and
biosynthetic secretory trafficking
Fletcher, Sarah; Iqbal, Mudassar; Jabbari, Sara; Stekel, Dov; Rappoport, Joshua
DOI:
10.1371/journal.pone.0111176
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Fletcher, SJ, Iqbal, M, Jabbari, S, Stekel, D & Rappoport, JZ 2014, 'Analysis of occludin trafficking,
demonstrating continuous endocytosis, degradation, recycling and biosynthetic secretory trafficking', PLoS ONE,
vol. 9, no. 11, e111176. https://doi.org/10.1371/journal.pone.0111176
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Eligibility for repository : checked 17/02/2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
RESEARCH ARTICLE
Analysis of Occludin Trafficking,
Demonstrating Continuous Endocytosis,
Degradation, Recycling and Biosynthetic
Secretory Trafficking
Sarah J. Fletcher1*, Mudassar Iqbal2, Sara Jabbari3, Dov Stekel2, Joshua Z.
Rappoport4
1. The Centre for Cardiovascular Sciences, Institute of Biomedical Research, University of Birmingham,
Birmingham, United Kingdom, 2. School of Biosciences, University of Nottingham, Sutton Bonington Campus,
Leicestershire, United Kingdom, 3. School of Mathematics and Institute for Microbiology and Infection,
University of Birmingham, Birmingham, United Kingdom, 4. Northwestern University, Feinberg School of
Medicine, 303 E. Chicago Avenue, Chicago, Illinois, United States of America
*s.j.fletcher@bham.ac.uk
Abstract
Tight junctions (TJs) link adjacent cells and are critical for maintenance of apical-
basolateral polarity in epithelial monolayers. The TJ protein occludin functions in
disparate processes, including wound healing and Hepatitis C Virus infection. Little
is known about steady-state occludin trafficking into and out of the plasma
membrane. Therefore, we determined the mechanisms responsible for occludin
turnover in confluent Madin-Darby canine kidney (MDCK) epithelial monolayers.
Using various biotin-based trafficking assays we observed continuous and rapid
endocytosis of plasma membrane localised occludin (the majority internalised
within 30 minutes). By 120 minutes a significant reduction in internalised occludin
was observed. Inhibition of lysosomal function attenuated the reduction in occludin
signal post-endocytosis and promoted co-localisation with the late endocytic
system. Using a similar method we demonstrated that ,20% of internalised
occludin was transported back to the cell surface. Consistent with these findings,
significant co-localisation between internalised occludin and recycling endosomal
compartments was observed. We then quantified the extent to which occludin
synthesis and transport to the plasma membrane contributes to plasma membrane
occludin homeostasis, identifying inhibition of protein synthesis led to decreased
plasma membrane localised occludin. Significant co-localisation between occludin
and the biosynthetic secretory pathway was demonstrated. Thus, under steady-
state conditions occludin undergoes turnover via a continuous cycle of endocytosis,
recycling and degradation, with degradation compensated for by biosynthetic
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exocytic trafficking. We developed a mathematical model to describe the
endocytosis, recycling and degradation of occludin, utilising experimental data to
provide quantitative estimates for the rates of these processes.
Introduction
Tight Junctions (TJs) provide structural support to epithelial monolayers, regulate
paracellular permeability and serve as a barrier to plasma membrane protein
diffusion, maintaining apical-basolateral polarity [1, 2]. Numerous human
diseases, such as cystic fibrosis and polycystic kidney disease have been
demonstrated to involve loss of epithelial polarity [3]. The TJ protein occludin
forms homotypic linkages with occludin present in the lateral plasma membrane
of adjacent cells [1, 2]. Although occludin is a core member of the TJ complex that
links together neighbouring epithelial cells and regulates cell polarity, occludin has
also been shown to modulate signal transduction, function as a co-receptor for the
Hepatitis C Virus (HCV), and play functional roles during epithelial wound
healing [4–7]. Our recent work has demonstrated that immediately following
monolayer wounding, occludin at the wound edge is rapidly internalised by
clathrin-mediated endocytosis within minutes [4]. Other work performed in the
same epithelial model has demonstrated that hours following wounding, occludin
can be observed at the very leading edge of the migrating front, where it plays an
essential role by regulating the localisation of the Par3-aPKC polarity complex [6].
Although occludin is a key regulator of epithelial function and wound healing, the
trafficking of occludin has not been well characterised, either in the context of
apical-basolateral polarity, or during epithelial wound healing.
Different pathways have been demonstrated to regulate occludin trafficking,
potentially based upon the model system analysed [8–11]. Additionally, most of
the work focusing on the endocytic trafficking of occludin has employed stimuli
such as calcium depletion or acute growth factor treatment to induce endocytosis
of occludin and loss of epithelial barrier function [9, 11–13]. Although there has
not been much work performed examining steady-state occludin trafficking, the
work that has been performed has been contradictory. Studies by Morimoto et al,
2005 suggest that internalised occludin is predominantly recycled to the cell
surface in a Rab13 dependent manner [14], while earlier work indicates occludin
is a protein which undergoes rapid lysosomal degradation [15]. Clearly, to further
understand the contribution of occludin trafficking to disease pathogenesis,
detailed understanding of the mechanisms which regulate occludin localisation at
the plasma membrane under basal conditions is required.
We have taken cultured monolayers of Madin-Darby canine kidney (MDCK)
cells and employed biotin-based biochemical assays and imaging studies to
evaluate occludin trafficking. We specifically focused on trafficking of endogenous
occludin during the initial stages of epithelial polarisation in serum-starved steady
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state conditions. Our results demonstrate that occludin undergoes continuous
endocytosis, with the majority of occludin internalised from the plasma
membrane within 30 minutes. Following internalisation, intracellular occludin is
subsequently lost from detection. We investigated two hypotheses for this loss of
intracellular occludin signal: 1) lysosomal degradation, 2) recycling and return to
the plasma membrane. Our analyses have demonstrated that this loss of
internalised occludin is primarily due to lysosomal degradation, but approxi-
mately 20% is returned back to the plasma membrane via recycling endosomes.
Although low level occludin recycling has been demonstrated, a compensatory
mechanism must exist in order to replace degraded occludin and maintain
occludin homeostasis. Our studies have demonstrated that this loss of occludin is
compensated for with newly synthesised occludin which enters the plasma
membrane after production. Thus, these results indicate that at steady-state,
occludin has only a brief cell surface half-life and that occludin undergoes a
constant cycle of endocytic degradative, low-level recycling and biosynthetic
secretory trafficking.
Given the experimental data, it is possible to use a dynamical mathematical
model coupled with statistical inference techniques to estimate the rates of the
molecular processes [16]. We have used such a model to estimate the rates of
endocytosis, recycling and degradation of occludin from the experimental data.
Moreover, the model predicts that these rates are likely to have slowed
considerably as a result of the experimental procedures. However, the rates then
recover during the course of the experiment. Thus, together our results represent
the first systematic understanding of steady-state occludin trafficking and provide
a dynamical mathematical model that will be useful in the understanding of
occludin trafficking in polarised cells and during disease processes.
Experimental
Cell culture
MDCK (CCL-34 ATCC) epithelial cells were cultured and maintained in DMEM
supplemented with 10% Foetal Bovine Serum (FBS), 1% Pen/Strep (both Lonza)
in humid conditions at 37 C˚ with 5% CO2.
Cell surface biotinylation
Assay 1 - occludin internalisation
MDCK cells were plated into a 6 well plate and 24 hour post-plating the confluent
monolayer was serum starved for 1 hour in serum free DMEM in the presence of
either DMSO (control) or 250 nM Bafilomycin A (BafA), in humid conditions at
37 C˚ with 5% CO2. All reagents were prepared according to the manufacturer’s
instructions (Pierce). After serum starvation, the cells were washed in ice cold PBS
(Lonza) at 4 C˚. The cells were incubated with Biotin solution at 4 C˚ for 1 hour.
Cells were washed in PBS, transferred to serum free DMEM pre-warmed to 37 C˚
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containing either 250 nM BafA (Calbiochem) or DMSO (Sigma) incubated in
humid conditions at 37 C˚ with 5% CO2 for 0, 5, 15, 30, 60 or 120 minutes. After
the designated time-points the cells were washed in ice cold PBS, followed by
washes with pH 8.6 biotinylation wash buffer (0.5M Tris pH 7.5 (Fisher
Scientific), 0.1 M NaCl (Sigma)). Biotin was removed from cell surface proteins
by a 30 minute incubation at 4 C˚ with reducing buffer (0.5M Tris pH 7.5, 0.1M
NaCl, 15 mM NaOH (Sigma) and 0.1M Sodium 2-mercaptoethanesulfonate
(MESNA) (Sigma)). The total amount of plasma membrane localised biotinylated
occludin was measured using 2 dishes which were kept on ice post biotinylation,
undergoing neither the internalisation period nor cell surface reduction. All dishes
were washed in PBS, the cells lysed in 1% Triton-X100 plus Complete Mini-
cocktail protease inhibitor (Roche) for 1 hour on ice. Lysates were incubated
overnight in spin columns with NeutrAvidin beads (Pierce). Beads were washed in
wash buffer plus protease inhibitor, then incubated with 36 Laemmli sample
buffer plus 50 mM DTT, for 1 hour and the eluate collected and boiled at 95 C˚
for 15 minutes.
Assay 2 - occludin recycling
Cells were biotin labelled as described previously after serum starvation in serum
free DMEM. Cells were washed in PBS, transferred to serum free DMEM pre-
warmed to 37 C˚ and incubated at 37 C˚ in previously described conditions for a
30 minute internalisation period. Post-internalisation, all but 2 wells underwent
biotin removal from cell surface proteins by the previously described reduction
step. These wells were then quenched with 20 mM iodacetamide (Sigma)
(dissolved in PBS) at 4 C˚ for 30 minutes. Two of these wells were lysed as
described previously to enable us to quantify the intracellular biotinylated
occludin pool after 30 minutes internalisation. In the two remaining non-reduced
wells, cells were quenched as before then lysed to measure total biotinylated
occludin (plasma membrane and intracellular biotinylated occludin). The
remaining dishes were incubated at 37 C˚ in the previously described conditions
for 5, 15, 30 or 60 minutes. After each time-point two dishes were reduced and
quenched (to measure the intracellular biotinylated occludin pool) while two
dishes were quenched (to measure the total biotinylated occludin pool). Dishes
were lysed, the biotinylated proteins were pulled down with NeutrAvidin beads
and the proteins eluted from the beads and prepared as described previously.
Assay 3 - occludin degradation
All reagents were made up as described previously. MDCK cells were plated into a
6 well plate, 24 hour post-plating cells were washed in PBS, and then incubated
for 0, 30, 60, 120 or 240 minutes in serum free DMEM containing either DMSO
(control) or 10 mM cycloheximide (CHX). In treatments 0, 30 and 60 minutes the
cells were pre-incubated in serum free DMEM, so that in these conditions 2 hours
serum starvation occurred before biotinylation. Cell surface proteins were biotin
labelled as described previously. Cells were quenched in quenching buffer (Pierce),
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lysed, incubated with NeutrAvidin, and the biotinylated protein removed from
the NeutrAvidin beads and treated as described previously.
Western blot analysis
Samples from biotin-based recycling assays were run on SDS-PAGE followed by
Western blot analysis. For cell surface biotinylation assays 1 and 3, Western Blots
were performed as follows: PVDF membranes were probed with rabbit anti-
occludin (Invitrogen) primary antibody (1:500), followed by incubation with goat
anti-rabbit IgG horseradish peroxidase conjugated secondary antibody (Thermo
Fisher Scientific Inc; 1:10,000 dilution) and scanned using a CURIX 60 XoGraph
machine (AGFA). For cell surface biotinylation assay 2, proteins were transferred
onto Odyssey membrane, probed (1:500 dilution) rabbit anti-occludin (H-279,
Santa Cruz Biotechnology) and 1:10,000 donkey anti-rabbit IRDye 800CW (LI-
COR). Western Blots were scanned and the lower band corresponding to occludin
was quantified using an Odyssey Infrared Imaging system and software (LI-COR).
For film analysis, films were scanned then quantified using NIS Elements.
Alterations in antibodies and western blot visualisation technique arose due to an
Invitrogen anti-occludin batch difference rendering the antibody incapable of
recognising endogenous canine occludin. Thus we validated a Santa-Cruz anti-
occludin antibody. This antibody gave high background signal in HRP/Film
systems affecting densitometry results; switching to the LI-COR system abrogated
background noise.
In both systems, the ROI selection tool a box was drawn around the largest
band and the average intensity was measured. This box was used to measure the
average band intensity of other bands. Background intensity was measured using
the same ROI box moved to a non-band region in the same lane as the band
measured. These values were logged to Excel, the average band value was then
subtracted from the average background value. For the cell surface biotinylation
assay 1 the band intensity value was normalised against the average value for the
total plasma membrane biotinylated occludin sample. While in cell surface
biotinylation assay 2 the band intensity values for both the total occludin and
internalised occludin pools were normalised against the internalised pool value
after the initial 30 minutes internalisation period. In the cell surface biotinylation
assay 3, the band intensity value was normalised against the time 0 band intensity
for either the control or CHX treated cells. The values were obtained from 3
separate experiments and a Student’s t-test was performed to determine statistical
significance.
Immunocytochemistry, imaging and co-localisation analysis
MDCK cells were plated onto glass coverslips in 6 well plates. Cells were
transfected with CD63-GFP DNA, NPY-mRFP (gifts from Dr Jyoti Jaiswal,
George Washington University, Washington D.C., USA) or Rab11-GFP (kindly
given by Dr J. Norman, The Beatson Institute of Cancer research, Glasgow, U.K.)
Analysis of Occludin Trafficking
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using Lipofectamine 2000 (Invitrogen) (4 mg DNA and 20 ml Lipofectamine 2000;
incubated as manufacturer recommends). 24 hours post-transfection the
confluent monolayer was incubated in DMEM supplemented with 10% FBS, 1%
Pen/Strep containing (for experiments examining co-localisation with lysosomal
compartments cells were incubated in serum free DMEM containing either
250 nM BafA (Calbiochem) or as a control DMSO for 3 hours in humid
conditions at 37 C˚ with 5% CO2 prior to fixation). Cells expressing NPY-mRFP,
CD63-GFP or Rab11-GFP were washed in PBS (Lonza), fixed in 4% PFA
(Electron Microscopy Sciences) and permeabilised with 0.1% Triton-X100
(Sigma). Cells were blocked in PBS plus 10% Normal goat serum (Gibco) and
0.5% BSA (Sigma). Cells were then incubated with mouse anti-occludin
(Invitrogen), 1:100 dilution in block media, for 1 h. Following PBS washes, cells
were incubated with goat anti-mouse-AlexaFluor488 (in cells transfected with
NPY-mRFP) or donkey anti-mouse-AlexaFluor568 (Invitrogen) (in cells trans-
fected with Rab11-GFP or CD63-GFP), diluted 1:100 for 1 hour. Post-staining,
cells were washed in PBS and mounted onto glass slides using Vectashield with
DAPI (Vector Labs). BafA inhibition of lysosomal acidification: MDCK cells were
plated into 35 mm MatTek dishes, 24 hours post-plating media was removed and
replaced with 2 mls cell culture media plus 75 nM LysoTracker Red DND-99 and
either 250 nM BafA or DMSO. The cells were incubated for 2 hours in humid
conditions at 37 C˚ with 5% CO2. The media was removed and the cells washed in
37 C˚ pre-warmed imaging media (5% FBS in 10 mM HEPES–Hank’s balanced
salt solution (Sigma) pH 7.4). During imaging cells were maintained at 37 C˚.
Imaging
Cells were imaged using a Nikon A1R inverted confocal microscope using the
microscope objective (CFL Plan Apo 606 NA 1.49, Nikon). In all studies a Z-
stack with 500 nm increments was performed on each cell imaged, and the images
with most intracellular punctate occludin staining selected for analysis. GFP
constructs and AlexaFluor488 conjugated secondary antibodies were imaged
following excitation with the 488 nm line of an Argon-Ion laser 457–514 nM,
mRFP constructs, LysoTracker Red DND-99 and AlexaFluor568 conjugated
secondary antibodies were imaged after excitation with Green Diode 561 nm
laser. The camera utilised to acquire images was a 12-bit CCD (Ixon 1M EMCCD
camera controlled by NIS Elements AR version 3.1/3.2/4).
The system was controlled by Nikon Elements. Analysis of time lapse sequences
and still frames was completed using NIS-Elements AR version 3.1, 3.2 or 4
(Nikon). Data was logged into Excel (Microscoft).
Co-localisation analysis
Occludin co-localisation with CD63-GFP
The entire cytosol excluding cell-cell junction staining was selected. Subsequently
a Pearson’s coefficient comparing the CD63-GFP and occludin signals in the
region were obtained. A total of 19 cells were analysed from 3 independent
Analysis of Occludin Trafficking
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experiments. Pearson’s correlation values during control or BafA treatment were
compared using a Student’s t-test.
Occludin co-localisation with Rab11-GFP
Co-localisation analysis for Rab11-GFP was performed by drawing a square ROI
within the boundaries of the cell in the occludin image and measuring the
Pearson’s correlation co-efficient between intracellular occludin and Rab11-GFP
structures, to control for random alignment the occludin image was flipped
horizontally while the Rab11-GFP image remained in the same position and the
Pearson’s correlation coefficient repeated. 12 cells from 3 independent experi-
ments were analysed. Control and experiment Pearson’s correlation values were
analysed for statistical significance using a Student’s t-test.
Occludin co-localisation with NPY-mRFP
20 intracellular punctate structures per cell in the NPY-mRFP channel were
selected using the ROI function and superimposed over the occludin image. The
number of NPY-mRFP outlines which co-localise with occludin positive regions
were counted. For the control, these regions were moved from NPY-mRFP puncta
and again co-localisation with occludin was counted. 13 cells were measured from
3 independent experiments. The number of NPY-mRFP and occludin co-
localising vesicle for control and experiment were compared using a Student’s t-
test.
Parameter inference methodology
The inference of parameters of the dynamical model was carried out using a
Markov Chain Monte Carlo (MCMC) approach, by embedding the mathematical
model and experimental data in the inference framework. Specifically, we used
Delayed Rejection and Adaptive Metropolis (DRAM) method (described in
[17, 18]) and implemented as a MATLAB toolbox (http://helios.fmi.fi/,lainema/
mcmc/).
The experimental data under consideration comprise the above experiments
quantifying the processes of endocytosis, degradation, and recycling of occludin.
Given the experimental data and parameter values (in the vector h), we define
the likelihood function in eq. (1), assuming Gaussian noise. Here Y is the data and
Yˆ is the model output. A sub-routine, calculating the sum of squares term in eq.
(1) is fed into the DRAM method.
L h Yjð Þ~Pni~1
1
ﬃﬃﬃﬃﬃﬃﬃﬃ
2ps
p e{
1
2s2
(Yi{Y^i)
2
ð1:1Þ
The range for parameters gmax and rmax was defined as [0, 10], for r as [0, 1] while
for a, and c as [0, 0.5]. Initial proposal covariance matrix was defined as I(5)*0.1,
where I(5) is a 565 identity matrix. With suitable initial values, we ran the
DRAM method for 30000 iterations, 2000 burn-ins, and initial s2 as 0.1 with
corresponding weight N0 (see [18] for definition) as 10. Adaptation was
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performed every tenth iteration. All other parameters of DRAM have their default
values.
Results
In order to analyse the potential for endocytosis of occludin during the initial
stages of epithelial polarisation, we have made use of a powerful biochemical
endocytic trafficking assay [19, 20]. The application of biotin-conjugated NHS
esters to cells at 4 C˚ selectively biotinylates lysine residues on the extracellular
domains of membrane proteins. When cells are re-incubated at 37 C˚ these
membrane proteins can undergo endocytosis and will be transported into the cell.
If a biotinylation reagent is used that includes a disulfide bond between the biotin
and the NHS group, then biotin linked to proteins remaining in the plasma
membrane can be removed by addition of a reducing agent. If the reducing agent
is not membrane permeant, then the biotinylated proteins that have been
internalised through endocytosis will be ‘‘protected’’ from reduction, and will be
retained and available for precipitation with NeutrAvidin beads.
As depicted in Figure 1, in confluent monolayers of MDCK cells in culture
occludin undergoes continuous steady-state endocytosis. Depicted on a
representative blot (Figure 1A) and quantification of 3 experiments (Figure 1B)
the internalised intracellular occludin signal rises and subsequently falls. The
halftime for internalisation in this study is approximately 15 minutes and nearly
all of the occludin present at the plasma membrane undergoes endocytosis within
approximately 30 minutes. Extending the time of our analyses beyond this point
revealed that the amount of biotinylated occludin present inside the cell post-
internalisation subsequently decreased. This decrease in intracellular occludin
signal at later time-points indicates a reduction in the level of intracellular
occludin following internalisation. There are two hypotheses that could explain
the loss of occludin signal subsequent to endocytosis, either the occludin could be
recycled back to plasma membrane or undergo degradation.
To determine if the decrease in intracellular occludin signal observed following
endocytosis was due to degradation we treated cells with BafA, which inhibits
lysosomal acidification and function (Figure S1) [21]. As shown in Figure 1, BafA
significantly attenuated the decrease in occludin signal between 30 and
120 minutes approximately 3 fold. Therefore, the majority of occludin loss
following endocytosis appears to be due to lysosomal degradation.
As a means of further testing this hypothesis, we performed a series of
microscopy studies to determine the intracellular localisation of occludin. We
employed CD63-GFP (validated by co-localisation with LysoTracker in Figure S2)
as a marker of the late endocytic/lysosomal compartment and tested the extent to
which occludin was observed to be coincident with CD63 [22]. When
immunocytochemistry for occludin was performed in control cells, a very small
degree of co-localisation with CD63 was observed (Figure 2A,B). However, the
juxtanuclear CD63 positive compartment (in yellow in Figure 2A), was observed
Analysis of Occludin Trafficking
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Figure 1. Steady-state endocytosis and degradative trafficking of occludin. A confluent monolayer of
MDCK cells were serum starved in the presence of either DMSO or 250 nm BafA. Cell surface proteins were
biotinylated and trafficking allowed to recommence for designated time-points in the presence of DMSO or
BafA. Cell surface biotinylated proteins were reduced, thus only internalised proteins remain biotinylated.
Biotinylated proteins were pulled down with NeutrAvidin beads. Protein abundance was quantified by western
blot analysis. (A) Treatment with BafA (inhibitor of lysosomal degradation), attenuates the decrease in
occludin signal following endocytosis observed in DMSO treated control cells. (B) Quantification of 3 repeats
of the experiments shown in (A). (C) Quantification of the decrease in occludin signal between 30 and
120 minutes comparing control to BafA treatment. * p#0.05.
doi:10.1371/journal.pone.0111176.g001
Analysis of Occludin Trafficking
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to greatly increase with occludin staining following incubation in BafA. Thus,
consistent with our above biochemical analyses, BafA treatment resulted in
increased co-localisation of occludin to late endosomal/lysosomal compartments (
Figure 2A,B). As a very small amount of occludin will be undergoing degradation
at any single point, and localisation with degradative compartments could render
the protein undetectable by immunostaining, it is not surprising that there is little
occludin signal co-localising with CD63 prior to BafA treatment. However, these
Figure 2. Co-localisation between internalised occludin and late endosome/lysosomal compartments
increases after BafA treatment. Incubation with BafA increases co-localisation between occludin and CD63-
GFP in comparison to control treated cells. A confluent monolayer of MDCK cells transiently expressing
CD63-GFP were incubated with DMSO or 250 nm BafA for 2 hours prior to fixation and immuno-localisation
with mouse anti-occludin (1:100). Cells were imaged by confocal microscopy. (A) Confocal image showing co-
localisation between occludin and CD63-GFP in the presence of DMSO or BafA. (B) Quantification of 3
repeats of the experiments shown in (A) with a minimum of 19 cells analysed of each condition. *** p#0.001.
doi:10.1371/journal.pone.0111176.g002
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results confirm our previous observations and demonstrate that occludin
undergoes continuous endocytosis and a high level of degradation.
After examining the role of the degradatory pathway in regulation of occludin
localisation at the plasma membrane, it was noted that in BafA treated cells there
is still a modest reduction in the amount of internalised intracellular occludin
from time 30 minutes to 120 minutes, despite inhibition of lysosomal compart-
ment acidification. This could indicate that a small percentage of internalised
occludin is being recycled back to the plasma membrane. We investigated this
hypothesis using a more complex biotin-based recycling assay which enabled us to
quantify the amount of internalised occludin remaining within the cell and the
amount returned to the plasma membrane (the intracellular occludin pool
subtracted from the total occludin pool) at various time-points after an initial
30 minute internalisation period. As demonstrated in Figure 3, there are higher
occludin levels in the total occludin pool samples than in the internalised samples
suggesting that post-internalisation occludin is being returned back to the plasma
membrane. This was quantified in figure 3B, where occludin levels have been
expressed as a percentage of the total amount of occludin internalised (lane
Time50 Intracellular occludin Figure 3A). Figure 3B demonstrates a steady
decrease in both the total occludin pool and the intracellular occludin pool
consistent with earlier findings that occludin undergoes a high level of
degradation. We also observed a general increase in the ratio of internalised
biotinylated occludin to total biotinylated occludin as time increases (Figure S3)
with approximately 20% of the internalised occludin being recycled at each time-
point.
This data has led us to conclude that occludin undergoes low level recycling.
We tested this hypothesis further using co-localisation analysis between a marker
of the recycling pathway (Rab11-GFP) [23] and endogenous occludin. Co-
localisation was identified between exogenous Rab11 and occludin at peripheral
punctate structures (Figure 4a), co-localisation analysis demonstrates this level of
co-localisation to be statistically significant (Figure 4b). Interestingly, when co-
localisation analysis was performed between Rab4-GFP and occludin, no
significant level of co-localisation was observed (data not shown). Therefore, this
data suggests internalised occludin undergoes recycling back to the plasma
membrane via Rab11 positive endosomal compartments alongside degradation.
Our above results suggest that endocytic recycling may only play a minor role
in the trafficking of occludin in this system and that a large proportion of
occludin is subject to lysosomal degradation, therefore the next question to
address was how the occludin at the plasma membrane lost to degradation is
being replaced. We tested the hypothesis that the occludin entering the plasma
membrane at steady-state to replenish that lost by endocytosis and degradation
originates from the biosynthetic pathway. Thus, our next step was to perform cell
surface biotinylation to determine the plasma membrane levels of occludin
following incubation in the protein synthesis inhibitor CHX [24]. Importantly
these were not assays of occludin trafficking directly, but a measure of the amount
of occludin present in the plasma membrane after incubation in CHX for different
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periods of time. This is because if endocytosis and degradation continue and
occludin is undergoing constant biosynthetic trafficking into the plasma
membrane, CHX treatment will result in an eventual loss of occludin from the
plasma membrane.
As demonstrated in Figure 5, following incubation in CHX the amount of
occludin observed available for biotinylation in the plasma membrane (
Figure 5A,C) and in whole cell lysates (Figure 5B) are both greatly reduced.
Figure 3. Endocytic occludin recycling. A confluent monolayer of serum starved MDCK cells were
biotinylated then warmed to induce occludin internalisation for 30 minutes followed by biotin removal from
plasma membrane proteins. Trafficking was allowed to recommence for various timescales and at each time-
point the total occludin pool (plasma membrane (PM)+intracellular occludin pool) and the intracellular occludin
pool were quantified by additional reduction/quenching steps. Biotinylated proteins were pulled down with
NeutrAvidin beads. Occludin abundance was quantified by Western blot analysis. (A) Western blot analysis
demonstrating both the total and intracellular occludin pool at various time-points (after a 30 minute
internalisation period). (B) Quantification of 3 repeats of the experiments shown in (A) measuring the total
occludin levels and the intracellular occludin levels expressed as a percentage of the intracellular pool post-
internalisation.
doi:10.1371/journal.pone.0111176.g003
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Quantification demonstrated that CHX treatment for 4 hours reduced the cell
surface levels of occludin by approximately 50%, while control cells showed no
alteration in the amount of plasma membrane occludin. Therefore, these
observations suggest that at serum-starved steady state new occludin trafficked
through the biosynthetic system replenishes that lost by endocytosis and
degradation.
In order to further test this hypothesis we evaluated whether occludin co-
localises with a marker for the biosynthetic secretory pathway, Neuropeptide Y
(NPY) [25]. As depicted in Figure 6 significant co-localisation between occludin
and NPY was observed. When controlled for random co-localisation approxi-
mately 50% of NPY labelled secretory vesicles were positive for occludin. Thus,
this confirms the biosynthetic trafficking of occludin at serum-starved steady
state, and taken together these observations demonstrate that occludin undergoes
a continuous cycle of biosynthetic exocytic and degradative endocytic trafficking,
with a small amount of recycling.
Figure 4. Co-localisation between internalised occludin and recycling endosome markers. A confluent
monolayer of MDCK cells transiently expressing Rab11-GFP were fixed and immuno-localisation with mouse
anti-occludin (1:100) was performed. Cells were imaged by confocal microscopy. (A) Confocal image showing
co-localisation between occludin and Rab11-GFP. (B) Quantification of 3 repeats of the experiments shown in
(A) with a minimum of 12 cells analysed of each condition. *** p#0.001.
doi:10.1371/journal.pone.0111176.g004
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The mathematical model consists of two equations, one for the membrane-
bound occludin (M) and one for internal occludin (I) (Figure 7). The model
includes the processes of endocytosis, recycling and degradation of occludin. The
model also includes a slowing of the endocytosis and recycling pathways due to
the cooling of the cells as part of the experiment, and the recovery of these
processes once the cells have been returned to 37 C˚.
The model shows an excellent fit to the majority of the data (Figure 7), with
only one data point lying outside the region of certainty of the model fits. Thus
Figure 5. Inhibition of protein synthesis reduces the amount of plasma membrane localised occludin.
Serum starved MDCK cells were incubated with serum free DMEM plus DMSO (control) or 10 mM CHX for
varying time-points. Cell surface proteins were then biotinylated and pulled down with NeutrAvidin beads.
Plasma membrane abundance of occludin was quantified by Western blot analysis. (A) Incubation with CHX
reduces both whole cell lysate and plasma membrane occludin levels. (B) Quantification of 3 independent
experiments measuring whole cell lysate levels of occludin 4 hours post-CHX treatment normalised to Time 0.
(C) Quantification of 3 independent experiments measuring plasma membrane levels of occludin 4 hours
post-CHX treatment normalised to Time 0. p#0.05 and ** p#0.01.
doi:10.1371/journal.pone.0111176.g005
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the model description and parameters are consistent with the experimental data.
According to the model fit, the rates of endocytosis and recycling are appreciably
impacted by the cooling of the cells, so that at the start of the experiment, the rates
of these processes are only 2% of their maximal values. The rates recover to their
maximal value with half-life of 32 minutes (as can be calculated from the
parameter values given in Figure 7). The maximal rates of endocytosis and
recycling both have half-times of under 1 minute – so these are very rapid –
although immediately following cooling these are predicted to be slower at
7.5 minutes and 11.4 minutes respectively. The rate of degradation of occludin
(assumed to be constant) is predicted to be considerably slower, with a half-time
of 53 minutes.
Figure 6. Co-localisation between internalised occludin and markers of the biosynthetic secretory
pathway. A confluent monolayer of MDCK cells transiently expressing NPY-mRFP were fixed and immuno-
localisation with mouse anti-occludin (1:100) was performed. Cells were imaged by confocal microscopy. (A)
Confocal image showing co-localisation between occludin and NPY-mRFP. (B) Quantification of 3 repeats of
the experiments shown in (A) with a minimum of 13 cells analysed of each condition. *** p#0.001.
doi:10.1371/journal.pone.0111176.g006
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This model has been compared with a simpler model that does not consider the
impact of cooling on the endocytosis and recycling pathways. Such a model is
unable to fit the data (Figure 8) because it cannot reconcile the different time
scales observed in the experimental data.
Discussion
TJs are essential to epithelial polarity and together have been implicated in both
genetic and infectious diseases [1–3, 7]. In particular occludin is emerging as a
regulator of numerous physiological and pathological processes both within the
TJ complex and through other mechanisms [4–7]. Thus, both the steady state and
regulated trafficking of occludin and other TJ proteins have been the subject of a
great deal of recent interest [9, 11–13, 26–29]. However, a detailed understanding
of the trafficking pathways that regulate occludin localisation has yet to emerge.
Thus, we performed a series of biochemical and microscopy studies to determine
Figure 7. Model (red lines) comparison with experimental data (blue lines). The grey spreads illustrate the model output obtained using 50 random
values of parameters from the posterior distribution. The model consists of two variables: M(t) (membrane occludin) and I(t) (internal occludin). Occludin is
assumed to undergo endocytosis, recycling and degradation at rates g(t), r(t) and c respectively. The resulting equations are dM/dt52g(t)M+r(t)I, dI/
dt5g(t)M2(r(t)+c)I. g and r are taken to be time-dependent following our finding that a linear version of the model cannot fit the data (Figure 8). We conclude
that the experimental procedure that cells be cooled negatively impacts on these processes, which eventually return to maximal rates during the recovery
period when cells are warmed. To represent this we use logistic functions: g(t)5gmaxg0e
rt/(gmax+g0(ert21)), and likewise for r(t). g0 and r0 represent the rates
of endocytosis and recycling immediately following cooling and are assumed to be a fraction of the maximal rates, i.e. g05agmax and r05armax where
0,a,1 and r is the rate of recovery of these processes. (A) and (B) correspond with the data in Figure 1B (steady-state endocytosis and degradative
trafficking of occludin) and (C) and (D) to those ofFigure 3B (endocytic occludin recycling). In (A) and (B) all occludin is initially on the membrane (M(0)5100,
I(0)50) and in (B) degradation is inhibited via addition of BafA, hence c50. In (C) and (D) all occludin is initially internal (M(0)50, I(0)5100). Note that, to
correspond with our experimental data, in (C) total occludin is plotted (i.e. membrane and internal occludin), while in (D) only internal occludin is shown.
Parameters are estimated to be gmax54.64(¡2.1) min
21, rmax53.05(¡1.56) min
21, r50.12(¡0.15) min21, a50.02(¡0.05) and c50.013(¡0.002) min21,
where the standard deviations are calculated from the marginal posterior distributions for each parameter.
doi:10.1371/journal.pone.0111176.g007
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the mechanisms that regulate the presence of occludin in the plasma membrane of
MDCK cells, a very well characterised epithelial model [30–32].
First we analysed endocytosis of occludin using a biotinylation based
biochemical assay [19, 20]. The results of these studies identified a continuous and
rapid endocytosis of occludin at serum-starved steady state. Subsequently the
internalised occludin was lost from detection. We then demonstrated through
pharmacological inhibition studies that the decrease in occludin signal following
endocytosis was due to lysosomal degradation. This hypothesis was confirmed
through both biochemical studies, as well as co-localisation analyses with a marker
of the late endocytic system, CD63 [22]. This is consistent with evidence from
previous studies where occludin has been suggested to undergo post-translational
modifications such as ubiquitination and phosphorylation, increasing interactions
with degradatory pathway trafficking proteins such as the E3 ubiquitin ligase itch,
epsin and epidermal growth factor receptor pathway substrate clone 15 (Eps15)
[33].
Although our data indicate that a high level of internalised occludin is
degraded, we also investigated the potential for occludin recycling after
internalisation. A complex biotin-based recycling assay was employed to examine
the role of recycling in regulation of occludin at the plasma membrane. Again we
Figure 8. Linear model (red lines) comparison with the experimental data (blue lines). The grey spreads illustrate the model output obtained using 50
random values of parameters from the posterior distribution. (A) and (B) use data taken from the steady-state endocytosis and degradative trafficking of
occludin experiment (M(0)5100, I(0)50), see Figure 1B, both representing internal occludin with no degradation occurring in (B) (c50). Data in (C) and (D)
are both obtained from the endocytic occludin recycling experiment (M(0)50, I(0)5100), see Figure 3B, the first being the total occludin (M(t)+I(t)), and the
second internal occludin. The model equations are given by dM/dt52gM+rI, dI/dt5gM2(r+c)I, i.e. the only change from the model in the main text is that
the rates of endocytosis and recycling are constant. For all high likelihood parameter values, the initial rise of internalized occludin in the trafficking
experiments is considerably faster than experimentally observed. This suggests the necessity of a slower time scale, which is included in the main model as
the rate of recovery from cooling.
doi:10.1371/journal.pone.0111176.g008
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observed a high level of internalised occludin undergoing degradation. We also
identified that approximately 20% of internalised occludin was recycled back to
the plasma membrane. This was further confirmed in co-localisation studies
where we saw a statistically significant co-localisation between the recycling
endosome marker Rab11-GFP [23] and endogenous internalised occludin.
Some previous analyses of the continuous constitutive trafficking of TJ proteins
have identified a role for endocytic recycling in maintaining plasma membrane
levels following endocytosis. However, although both the ESCRT complex and in
particular PIKfyve have been implicated in the recycling of claudin, occludin
localisation was unaffected by inhibiting these proteins [26, 27]. Interestingly, one
study suggested that Rab13 dependant occludin recycling could occur in MTD-1A
cells, albeit with a small percentage of total cell surface occludin [28]. Thus, our
results are consistent with previous findings suggesting occludin undergoes
recycling back to the plasma membrane, however only a small proportion of that
which is internalised makes it back to the plasma membrane.
Together, these data demonstrate occludin has a short cell surface half-life and
undergoes a continuous process of endocytosis coupled to degradation and low-
level recycling during the initial stages of cell polarisation. However, if the
majority of internalised occludin is subject to degradation, then it must be
replenished through some mechanism.
Our next step was to determine if biosynthetic trafficking might be responsible
for compensating for the loss of plasma membrane occludin due to endocytosis
and degradation. We then demonstrated that if we inhibited protein synthesis
with CHX and endocytosis and degradation continued, the amount of occludin
present in the plasma membrane decreased. Further in support of our conclusion
that biosynthetic trafficking accounts for the exocytic replenishment of occludin
following endocytosis, we observed significant co-localisation of occludin with the
marker of the secretory pathway NPY. Therefore, taken together, our results
demonstrate that at serum-starved steady state occludin undergoes a continuous
cycle of endocytosis, low-level recycling and degradation which is matched by
biosynthetic exocytic trafficking (Figure 9).
The mathematical model has made quantitative predictions for the rates of
endocytosis and recycling. These predictions suggest that these rates are very
rapid, and that some of the slower time scales observed in the experimental data
may be due to a slowing of these pathways due to the cooling regime used to
generate the experimental data. This is consistent with previous studies as it is well
know that incubation of cells at 4 C˚ inhibits endocytosis [34], and a recovery
period to allow trafficking to recommence following re-warming is not at all
surprising.
However, it is also important to take into account the level of uncertainty
associated with the parameter estimations. The approach we have taken to model
fitting is a Bayesian approach that produces what is known as ‘‘posterior
distributions’’ for each parameter (Figure 10). These represent our level of
knowledge about the parameter values given the experimental data and the model.
The posterior distributions for the occludin degradation rate, the rate of recovery
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from cold, and the impact of the cold show clearly defined peaks with a tight
distribution about optimal values. On the other hand, the distributions for the
maximal rates of endocytosis and recycling are considerably broader, indicating
less certainty in our knowledge of these rates. Put another way, these distributions
Figure 9. Diagram demonstrating occludin trafficking under steady-state conditions. During the initial
stages of MDCK cell polarisation occludin undergoes endocytosis followed by lysosomal degradation and
low-level recycling. This is coupled to occludin biosynthesis in order to maintain plasma membrane occludin
homeostasis.
doi:10.1371/journal.pone.0111176.g009
Figure 10. Posterior distributions of the estimated parameters. c, a and r display particularly tight distributions around their means, the implication being
that their estimates are relatively reliable. gmax and rmax (the maximal rates of endocytosis and recycling), on the other hand, display a much broader
distribution, meaning that our knowledge of these parameters given the experimental data is less certain.
doi:10.1371/journal.pone.0111176.g010
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indicate that there are other combinations of parameter values for the maximal
rates that fit the data almost as well. Better estimates for these rates would require
higher resolution time courses for longer periods of time.
There are two data points that the model does not fit especially well. The first of
these is the very high level of internalized occludin observed after 30 minutes in
the DMSO internalization experiment. This may be due to temperature effects on
lysosomal degradative trafficking similar to that observed in endocytosis studies.
Previous studies have demonstrated a temperature reduction to 20 C˚ led to
decreased lysosomal degradation and accumulation of internalised dextran in late
endosomal compartments [35]. These decreased degradation kinetics will be
slower in comparison to the prediction of the model. However, degradative
trafficking post-endocytosis is complex, involving multiple pathways. Thus
incorporation of a recovery period into the degradative trafficking model would
not be as straightforward as an endocytosis delay. The second is the lower level of
internalized occludin observed after 120 minutes following the addition of BafA.
This could be modelled with a partial, rather than total, inhibition of degradation
in the presence of BafA. In each case, however, in order to fit these data, the model
would require modifications to include extra parameters. It would not be possible
to estimate these parameters in a statistically valid way, as each such parameter
would depend on only a single data point.
Our detailed mechanistic analysis of occludin trafficking at serum-starved
steady state is relevant for many reasons. TJ are critical in the connections between
cells and the maintenance of apical basolateral polarity [1, 2]. Although regulated
trafficking of TJ proteins has been the subject of several recent investigations,
constitutive trafficking has not been as well studied [9, 11–13, 36]. Thus, these
results are important for two key reasons: serum-starved steady state trafficking is
the baseline upon which physiologically relevant alterations and perturbations
must be built. Furthermore, occludin has already been shown to function beyond
a role in TJ formation [4–7]. Therefore, the analysis and modelling of the serum-
state steady state trafficking of occludin represents a key step in understanding the
roles of this interesting and important protein in numerous physiological and
pathological contexts.
Supporting Information
Figure S1. BafA treatment inhibits lysosomal acidification and retention of
LysoTracker in lysosomal compartments. A confluent monolayer of MDCK cells
were incubated in culture media plus 75 nM LysoTracker Red DND-99 and either
250 nM BafA or DMSO for 2 hours. Live cells were imaged by confocal
microscopy. A) Confocal image showing LysoTracker staining in MDCK cells
treated with either DMSO or BafA. (B) Quantification of 3 repeats of the
experiments shown in (A) with average intensities quantified from a minimum of
20 cells analysed per experiment.
doi:10.1371/journal.pone.0111176.s001 (TIF)
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Figure S2. LysoTracker Red DND-99 co-localises with CD63-GFP. A confluent
monolayer of MDCK cells transiently expressing CD63-GFP were incubated with
75 nM LysoTracker Red DND-99 for 2 hours. Live cells were imaged using
confocal microscopy. A high level of co-localisation was observed between CD63-
GFP and LysoTracker positive structures (n51).
doi:10.1371/journal.pone.0111176.s002 (TIF)
Figure S3. Increased ratio between internal levels of biotinylated occludin and
total levels of biotinylated occludin was observed over time. A confluent
monolayer of serum starved MDCK cells were biotinylated then warmed to induce
occludin internalisation for 30 minutes followed by biotin removal from plasma
membrane proteins. Trafficking was allowed to recommence for various
timescales and at each time-point the total occludin pool (plasma membrane
(PM)+intracellular occludin pool) and the intracellular occludin pool were
quantified by additional reduction/quenching steps. Biotinylated proteins were
pulled down with NeutrAvidin beads. Occludin abundance was quantified by
Western blot analysis. Ratio demonstrated the intracellular biotinylated
intracellular occludin divided by the total biotinylated occludin levels.
Quantification of 3 repeats of experiments.
doi:10.1371/journal.pone.0111176.s003 (TIF)
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